EP3585775
AZETIDINE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
20.2.2018:
6.4.2022:
18707874.6
:
19.2.2038
:
AZETIDINE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
20.2.2018
6.4.2022
:
Sanofi:
54, rue La Boétie, 75008 Paris, FR
:
SCHWINK, Lothar:
65926 Frankfurt am Main, DE
:
BUNING, Christian:
65926 Frankfurt am Main, DE
:
GLOMBIK, Heiner:
65926 Frankfurt am Main, DE
:
PÖVERLEIN, Christoph:
65926 Frankfurt am Main, DE
:
RITTER, Kurt:
65926 Frankfurt am Main, DE
:
HALLAND, Nis:
65926 Frankfurt am Main, DE
:
LOHMANN, Matthias:
65926 Frankfurt am Main, DE
:
17305189:
21.2.2017:
EP
:
EP2018054133:
20.2.2018
:
C07D 401/14, C07D 403/14, A61K 31/506, A61P 5/48